3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma
13
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Hodgkin Disease
5
Leukemia
4
Neoplasms
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Leukemia, Biphenotypic, Acute
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hemangioma
2
Enteropathy-Associated T-Cell Lymphoma
2
Stomatitis
1
Stomach Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peripheral Nervous System Diseases
1
Oral Ulcer
1
Neurotoxicity Syndromes
1
Neoadjuvant Therapy
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer Patients
1
Interventions
Cyclophosphamide
33
fludarabine phosphate
19
Peripheral Blood Stem Cell Transplantation
19
Mycophenolic Acid
17
Whole-Body Irradiation
15
Etoposide
15
Rituximab
14
Tacrolimus
13
Busulfan
12
Vincristine
11
Prednisone
11
Methotrexate
11
Filgrastim
11
Doxorubicin
11
Cyclosporine
11
Radiotherapy
10
Brentuximab Vedotin
10
Antilymphocyte Serum
10
Methylprednisolone
8
Cytarabine
8
Melphalan
7
Cisplatin
6
Ifosfamide
5
Gemcitabine
5
merphos
4
ibritumomab tiuxetan
4
Sirolimus
4
Flow Cytometry
4
Dexamethasone
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, Large-Cell, Anaplastic
×
Prednisolone
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled